ARCHIVES

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

This article is from The Cancer Letter archive.

Vol. 23 No. 29 | July 25, 1997

Download PDF Visit The Full Archive

Related Articles

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

Sausville to lead clinical research at Maryland.

December 5, 2003

Smoking/Health Program Seeks Grants; Ideas For RFAs RFPs Being Considered

December 5, 1980

Letter To The Editor: Humor Story On Dands

October 29, 1999

NCCS Networker Volume 2 Issue 2, Spring 1988

April 13, 1988